Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
0.75
0.02 (2.74%)
At close: Sep 05, 2025, 2:30 PM
0.75
0.00%
After-hours: Sep 05, 2025, 02:30 PM EDT
2.74% (1D)
| Bid | 0.7 |
| Market Cap | 7.78M |
| Revenue (ttm) | 849K |
| Net Income (ttm) | -11.45M |
| EPS (ttm) | -1.73 |
| PE Ratio (ttm) | -0.43 |
| Forward PE | -0.83 |
| Analyst | n/a |
| Ask | 0.75 |
| Volume | 7,663 |
| Avg. Volume (20D) | 292,656 |
| Open | 0.73 |
| Previous Close | 0.73 |
| Day's Range | 0.70 - 0.75 |
| 52-Week Range | 0.52 - 4.50 |
| Beta | 0.14 |
About BCLI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCLI
Website n/a
1 month ago
-28.21%
BrainStorm Cell Therapeutics is trading lower afte...
Unlock content with
Pro Subscription
1 month ago
-2.5%
BrainStorm Cell Therapeutics is trading lower after receiving a delisting notice from Nasdaq effective July 18, 2025.
3 weeks ago · seekingalpha.com
Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2025 Earnings Call TranscriptBrainstorm Cell Therapeutics Inc. (OTC:BCLI) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Company Participants Alla Patlis - Interim CFO & Controller Chaim Lebovits - President & CEO Ib...